IRIS

Sfoglia per Rivista  RADIOTHERAPY AND ONCOLOGY

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 39 a 58 di 137
Titolo Data di pubblicazione Autore(i) File
Head and neck cancer of unknown primary: recurrence pattern based on treatment volumes 1-gen-2022 Guaineri, A; Maddalo, M; Bastia, Mbde; Magrini, Sm; Toraci, C; Bossi, P; Paderno, A; Maroldi, R; Ravanelli, M; Piazza, C; La Mattina, S; Facheris, G; Volpi, G; Singh, N; Pastorello, E
HIGH DOSE TOMOTHERAPY TREATMENT OF LYMPH NODAL RELAPSE IN PROSTATE CANCER 1-gen-2008 Berardi, G; Alongi, F; Cozzarini, C; Landoni, C; Picchio, M; Fiorino, C; Guazzoni, G; Messa, C; Fazio, F; Di Muzio, N
High hypofractionation using beacon transponders in intermediate-risk prostate cancer: first results 1-gen-2017 Di Brina, L; D'Agostino, G; Franzese, C; Franceschini, D; Comito, T; De Rose, F; Navarria, P; Tozzi, A; Iftode, C; Ascolese, A; Clerici, E; Pasini, L; Benetti, A; Scorsetti, M
Hypofractionated adjuvant radiotherapy with helical Tomotherapy after radical prostatectomy: Planning data and toxicity results of a Phase I-II study 1-gen-2008 Cozzarini, C; Fiorino, C; Di Muzio, N; Valdagni, R; Salonia, A; Alongi, F; Broggi, S; Guazzoni, G; Montorsi, F; Rigatti, P; Calandrino, R; Fazio, F
Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis. 1-gen-2018 Navarria, P; Pessina, F; Franzese, C; Tomatis, S; Perrino, M; Cozzi, L; Simonelli, M; Bello, L; Clerici, E; Riva, M; Santoro, A; Scorsetti, M
Hypofractionated radiotherapy for ductal carcinoma in situ using VMAT: acute toxicity and cosmesis 1-gen-2017 De Rose, F; Fogliata, A; Franceschini, D; Iftode, C; Ascolese, Am; Comito, T; Di Brina, L; Tozzi, A; Franzese, C; Clerici, E; D'Agostino, Gr; Navarria, P; Lobefalo, F; Scorsetti, M
Hypofractionated stereotactic RS for patients with brain metastases. Outcome evaluation and toxicity 1-gen-2016 Navarria, P; Ascolese, A; D'Agostino, G; Villa, E; Clerici, E; Tozzi, A; Iftode, C; DE ROSE, F; Liardo, L; Comito, T; Franzese, C; Franceschini, D; Pessina, F; Riva, M; Bello, L; Reggiori, G; Scorsetti, M
Hypofractionated StereotaticRS for patients with brain metastases. Outcome evaluation and toxicity 1-gen-2016 Navarria, P; Ascolese, A; D'Agostino, G; Villa, E; Clerici, E; Tozzi, A; Iftode, C; De Rose, F; Liardo, L; Comito, T; Franzese, C; Franceschini, D; Pessina, F; Riva, M; Bello, L; Reggiori, G; Scorsetti, M
HYPOFRACTIONATED TOMOTHERAPY TREATMENT (HTT) IN PROSTATE CANCER LYMPH NODAL RELAPSE DETECTED BY 11CCHOLINE PET/CT 1-gen-2011 Berardi, G; Pappalardi, B; Fiorino, C; Cozzarini, C; Guazzoni, G; Calandrino, R; Di Muzio, Ng
Hypofractionated VMAT for early stage breast cancer: acute toxicity and cosmesis in 840 patients 1-gen-2016 Iftode, C; De Rose, F; Franceschini, D; Fogliata, A; Villa, E; Ascolese, Am; Navarria, P; D'Agostino, Gr; Franzese, C; Comito, T; Tozzi, A; Clerici, E; Liardo, Rle; Stravato, A; Scorsetti, M
IDENTIFICATION OF RESIDUAL METABOLIC-ACTIVE AREAS WITHIN NSCLC TUMOURS USING A PRE-RADIOTHERAPY FDG-PET-CT SCAN: A PROSPECTIVE VALIDATION 1-gen-2010 Aerts, H; Bussink, J; Oyen, W; van Elmpt, W; Folgering, A; Emans, D; Velders, M; De Ruysscher, D
Imaging hypoxia after oxygenation-modification: Comparing [F-18]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors 1-gen-2006 Troost, Egc; Laverman, P; Kaanders, Jham; Philippens, M; Lok, J; Oyen, W; van der Kogel, Aj; Boerman, Oc; Bussink, J
Imaging hypoxia: Comparing [18F]FMISO autoradiography with pimonidazole immunchistochemistry inhuman xenograft tumors 1-gen-2006 Bussink, J; Troost, Egc; Laverman, P; Kaanders, Jha; Philippens, M; Lok, J; Rennen, H; Oyen, W; Boerman, Oc; van der Kogell, Aj
In response to "Histopathologic validation of 3 '-deoxy-3 '-F-18-fluorothymidine PET for detecting tumour repopulation during fractionated radiotherapy in human FaDu squamous cell carcinoma in nude mice" 1-gen-2015 Troost, Egc; Hoeben, Baw; Laverman, P; Bussink, J; Oyen, W
Influence of "radioresistant" histologies on SBRT outcome for lung metastases 1-gen-2017 Franceschini, D; Cozzi, L; De Rose, F; Navarria, P; D'Agostino, Gr; Tomatis, S; Franzese, C; Comito, T; Lobefalo, F; Mancosu, P; Scorsetti, M
Intensity modulated protons: feasibility for hypofractionated hepatocellular carcinoma treatment 1-gen-2019 Cozzi, L; Comito, T; Fogliata, A; Franzese, C; Tomatis, S; Scorsetti, M
INTERMEDIATE REPORT OF A FASE I-II STUDY OF HIGH DOSE HYPOFRACTIONATED TOMOTHERAPY FOR LOCALIZED PROSTATE CANCER: PROMISINGLY HIGH BIOCHEMICAL CONTROL WITH MINIMAL RATE OF GRADE 3 TOXICITY 1-gen-2010 Di Muzio, N; Cozzarini, C; Fiorino, C; Berardi, G; Valdagni, R; Alongi, F; Pappalardi, B; Broggi, S; Calandrino, R; Guazzoni, G
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma 1-gen-2014 Navarria, Pierina; Reggiori, Giacomo; Pessina, Federico; Ascolese Anna, Maria; Tomatis, Stefano; Mancosu, Pietro; Lobefalo, Francesca; Clerici, Elena; Lopci, Egesta; Bizzi, Alberto; Grimaldi, Marco; Chiti, A; Simonelli, Matteo; Santoro, Armando; Bello, Lorenzo; Scorsetti, Marta
Is DIBH more robust than FB in VMAT left breast irradiation? Multicenter and multivendor analysis 1-gen-2019 Russo, S; Esposito, M; Hernandez, V; Saez, J; Nicolini, G; Vanetti, E; Rossi, F; Paoletti, L; Bastiani, P; Reggiori, G; Tomatis, S; Scorsetti, M; Mancosu, P
IS HYPOXIA PET IMAGE CONTRAST ENHANCED BY FASTER TRACER CLEARANCE? A SIMULATION STUDY 1-gen-2011 Moennich, D; Troost, E; Kaanders, J; Oyen, W; Alber, M; Thorwarth, D
Mostrati risultati da 39 a 58 di 137
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile